Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Medication
1.2.3 Minimally Invasive Surgery
1.2.4 Invasive Surgery
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Heartburn
1.3.3 Acid reflux disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Perspective (2018-2033)
2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Growth Trends by Region
2.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Region (2018-2023)
2.2.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Region (2024-2033)
2.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Dynamics
2.3.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Trends
2.3.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
2.3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
2.3.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Revenue (2018-2023)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Players (2018-2023)
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2022
3.5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Players Head office and Area Served
3.6 Key Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Type (2018-2023)
4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2024-2033)
5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Application (2018-2023)
5.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2018-2033)
6.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023)
6.4 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2018-2033)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023)
7.4 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2018-2033)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2018-2033)
9.2 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023)
9.4 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2018-2033)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Detail
11.1.2 AstraZeneca, Plc. Business Overview
11.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.1.4 AstraZeneca, Plc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.1.5 AstraZeneca, Plc. Recent Development
11.2 Addex Therapeutics
11.2.1 Addex Therapeutics Company Detail
11.2.2 Addex Therapeutics Business Overview
11.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.2.4 Addex Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.2.5 Addex Therapeutics Recent Development
11.3 Takeda Pharmaceutical Company Limited
11.3.1 Takeda Pharmaceutical Company Limited Company Detail
11.3.2 Takeda Pharmaceutical Company Limited Business Overview
11.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.3.4 Takeda Pharmaceutical Company Limited Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.3.5 Takeda Pharmaceutical Company Limited Recent Development
11.4 Rottapharm (Meda AB)
11.4.1 Rottapharm (Meda AB) Company Detail
11.4.2 Rottapharm (Meda AB) Business Overview
11.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.4.4 Rottapharm (Meda AB) Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.4.5 Rottapharm (Meda AB) Recent Development
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Detail
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.5.4 Pfizer, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.5.5 Pfizer, Inc. Recent Development
11.6 Eisai Co. Ltd.
11.6.1 Eisai Co. Ltd. Company Detail
11.6.2 Eisai Co. Ltd. Business Overview
11.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.6.4 Eisai Co. Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.6.5 Eisai Co. Ltd. Recent Development
11.7 The Procter & Gamble Company
11.7.1 The Procter & Gamble Company Company Detail
11.7.2 The Procter & Gamble Company Business Overview
11.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.7.4 The Procter & Gamble Company Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.7.5 The Procter & Gamble Company Recent Development
11.8 Mederi Therapeutics
11.8.1 Mederi Therapeutics Company Detail
11.8.2 Mederi Therapeutics Business Overview
11.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.8.4 Mederi Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.8.5 Mederi Therapeutics Recent Development
11.9 Aros Pharma
11.9.1 Aros Pharma Company Detail
11.9.2 Aros Pharma Business Overview
11.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.9.4 Aros Pharma Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.9.5 Aros Pharma Recent Development
11.10 Torax Medical, Inc.
11.10.1 Torax Medical, Inc. Company Detail
11.10.2 Torax Medical, Inc. Business Overview
11.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.10.4 Torax Medical, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.10.5 Torax Medical, Inc. Recent Development
11.11 BD
11.11.1 BD Company Detail
11.11.2 BD Business Overview
11.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.11.4 BD Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.11.5 BD Recent Development
11.12 EndoGastric Solutions
11.12.1 EndoGastric Solutions Company Detail
11.12.2 EndoGastric Solutions Business Overview
11.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.12.4 EndoGastric Solutions Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.12.5 EndoGastric Solutions Recent Development
11.13 Medigus Ltd.
11.13.1 Medigus Ltd. Company Detail
11.13.2 Medigus Ltd. Business Overview
11.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.13.4 Medigus Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
11.13.5 Medigus Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Medication
Table 3. Key Players of Minimally Invasive Surgery
Table 4. Key Players of Invasive Surgery
Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2018-2023)
Table 9. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2024-2033)
Table 11. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends
Table 12. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
Table 13. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
Table 14. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
Table 15. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players (2018-2023)
Table 17. Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2022)
Table 18. Ranking of Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Solution and Service
Table 22. Date of Enter into Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2018-2023)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Type (2024-2033)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2018-2023)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Application (2024-2033)
Table 32. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2024-2033) & (US$ Million)
Table 47. AstraZeneca, Plc. Company Detail
Table 48. AstraZeneca, Plc. Business Overview
Table 49. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 50. AstraZeneca, Plc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 51. AstraZeneca, Plc. Recent Development
Table 52. Addex Therapeutics Company Detail
Table 53. Addex Therapeutics Business Overview
Table 54. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 55. Addex Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 56. Addex Therapeutics Recent Development
Table 57. Takeda Pharmaceutical Company Limited Company Detail
Table 58. Takeda Pharmaceutical Company Limited Business Overview
Table 59. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 60. Takeda Pharmaceutical Company Limited Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 61. Takeda Pharmaceutical Company Limited Recent Development
Table 62. Rottapharm (Meda AB) Company Detail
Table 63. Rottapharm (Meda AB) Business Overview
Table 64. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 65. Rottapharm (Meda AB) Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 66. Rottapharm (Meda AB) Recent Development
Table 67. Pfizer, Inc. Company Detail
Table 68. Pfizer, Inc. Business Overview
Table 69. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 70. Pfizer, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 71. Pfizer, Inc. Recent Development
Table 72. Eisai Co. Ltd. Company Detail
Table 73. Eisai Co. Ltd. Business Overview
Table 74. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 75. Eisai Co. Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 76. Eisai Co. Ltd. Recent Development
Table 77. The Procter & Gamble Company Company Detail
Table 78. The Procter & Gamble Company Business Overview
Table 79. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 80. The Procter & Gamble Company Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 81. The Procter & Gamble Company Recent Development
Table 82. Mederi Therapeutics Company Detail
Table 83. Mederi Therapeutics Business Overview
Table 84. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 85. Mederi Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 86. Mederi Therapeutics Recent Development
Table 87. Aros Pharma Company Detail
Table 88. Aros Pharma Business Overview
Table 89. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 90. Aros Pharma Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 91. Aros Pharma Recent Development
Table 92. Torax Medical, Inc. Company Detail
Table 93. Torax Medical, Inc. Business Overview
Table 94. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 95. Torax Medical, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 96. Torax Medical, Inc. Recent Development
Table 97. BD Company Detail
Table 98. BD Business Overview
Table 99. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 100. BD Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 101. BD Recent Development
Table 102. EndoGastric Solutions Company Detail
Table 103. EndoGastric Solutions Business Overview
Table 104. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 105. EndoGastric Solutions Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 106. EndoGastric Solutions Recent Development
Table 107. Medigus Ltd. Company Detail
Table 108. Medigus Ltd. Business Overview
Table 109. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product
Table 110. Medigus Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023) & (US$ Million)
Table 111. Medigus Ltd. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type: 2022 VS 2033
Figure 3. Medication Features
Figure 4. Minimally Invasive Surgery Features
Figure 5. Invasive Surgery Features
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application: 2022 VS 2033
Figure 8. Heartburn Case Studies
Figure 9. Acid reflux disorders Case Studies
Figure 10. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Report Years Considered
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region: 2022 VS 2033
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Players in 2022
Figure 15. Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2022
Figure 17. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2018-2033)
Figure 19. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2018-2033)
Figure 23. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Region (2018-2033)
Figure 31. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2018-2033)
Figure 39. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Country (2018-2033)
Figure 43. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. AstraZeneca, Plc. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 46. Addex Therapeutics Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 47. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 48. Rottapharm (Meda AB) Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 49. Pfizer, Inc. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 50. Eisai Co. Ltd. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 51. The Procter & Gamble Company Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 52. Mederi Therapeutics Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 53. Aros Pharma Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 54. Torax Medical, Inc. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 55. BD Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 56. EndoGastric Solutions Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 57. Medigus Ltd. Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed